Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24065642 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Carmen María García-Martínez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service of Internal Medicine, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18012 Gr…. Hauptthemen laut MEDLINE: Papillomavirus Infections, Acquired Immunodeficiency Syndrome, HIV Infections, Sexual and Gender Minorities. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To determine the value of low-risk human papillomavirus (HPV) PCR to screen for “high-grade anal squamous intraepithelial lesion and anal cancer” (HSIL-plus), rate of patients with low-grade anal squamous intraepithelial lesion (LSIL) progressing to HSIL-plus, and progression-related factors. Prospective, longitudinal study of consecutive MSM-LHIV attended between May 2010 and December 2021 and followed for 43 months (IQR: 12–76). HIV-related variables were gathered at baseline, performing anal cytology for HPV detection/genotyping, thin-layer cytological study, and high-resolution anoscopy (HRA). Follow-up was annual when HRA was normal or LSIL, and post-treatment in cases of HSIL-plus, re-evaluating sexual behavior, viral-immunological status, and HPV infection of anal mucosa. The 493 participants had mean age of 36 years: CD4 nadir < 200 cells/uL in 23.1%, virological failure in 4.1%, and tetravalent HPV vaccine > 5 years earlier in 15%. HSIL-plus was ruled out in patients with monoinfection by low-risk HPV genotype and normal cytology (100% sensitivity, 91.9% specificity, PPV 2.9%, and NPV 100%). Progression from LISL to HSIL-plus occurred in 4.27% of patients within 12 months (IQR: 12–12): risk factors were acquisition of high-risk (HR: 4.15; 95% CI: 1.14–15.03) and low-risk (HR: 3.68 95% CI: 1.04–12.94) HPV genotypes, specifically genotype 6 (HR: 4.47, 95% CI: 1.34–14.91), and history of AIDS (HR: 5.81 95% CI: 1.78–18.92). Monoinfection by LR-HPV genotypes in patients with normal cytology is not associated with anal cancer or precursor lesions. Progression from LSIL to HSIL-plus, observed in
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Service of Internal Medicine, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18012 Granada, Spain.
- Service of Pathology, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18012 Granada, Spain.
- Unit of Infectious Diseases, Complejo Hospitalario de Jaén, 23007 Jaen, Spain.
- Unit of Infectious Diseases, Hospital Universitario Virgen de las Nieves, Instituto de Investigación Biosanitario de Granada (IBS-Granada), 18012 Granada, Spain.
ORCID-Profile: Javier López-Hidalgo, Carmen Hidalgo-Tenorio
Zitieren
APA
García-Martínez, C. M., Calle-Gómez, I., López-Hidalgo, J., Gómez-Ronquillo, P., Omar-Mohamed Balgahata, M., & Hidalgo-Tenorio, C. (2023). Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24065642
Vancouver
García-Martínez CM, Calle-Gómez I, López-Hidalgo J, Gómez-Ronquillo P, Omar-Mohamed Balgahata M, Hidalgo-Tenorio C. Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24065642
BibTeX
@article{GarcaMartnez2023,
author = {García-Martínez, Carmen María and Calle-Gómez, Inmaculada and López-Hidalgo, Javier and Gómez-Ronquillo, Patricia and Omar-Mohamed Balgahata, Mohamed and Hidalgo-Tenorio, Carmen},
title = {Role of Low-Risk HPV PCR Monoinfection in Screening for HSIL and Anal Cancer in Men Who Have Sex with Men Living with HIV},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24065642}
}
EUVIMED